Junctional epidermolysis bullosa with pyloric atresia - Symptoms, Causes, Treatment & Prevention

Junctional Epidermolysis Bullosa with Pyloric Atresia – A Complete Guide

Junctional Epidermolysis Bullosa with Pyloric Atresia (JEB‑PA)

Overview

Junctional epidermolysis bullosa with pyloric atresia (JEB‑PA) is a rare, inherited disorder that combines two serious problems:

  • Junctional epidermolysis bullosa (JEB): fragile skin that blisters and sloughs at the level of the dermal‑epidermal junction.
  • Pyloric atresia (PA):** a congenital blockage of the pylorus, the outlet of the stomach, which prevents food from passing into the small intestine.

The condition follows an autosomal recessive inheritance pattern, meaning a child must inherit a defective copy of the responsible gene from each parent.

Who is affected?

JEB‑PA is seen worldwide but is most frequently reported in infants of consanguineous (related) parents. Because it is so rare, precise prevalence figures are difficult to obtain; however, epidemiologic surveys estimate that junctional EB overall occurs in roughly 1 per 200,000 live births, and JEB‑PA accounts for < 5 % of those cases (NIH, 2020).

Typical age of onset

Signs are evident at birth or within the first few days of life. The pyloric obstruction usually presents with feeding intolerance shortly after the infant begins oral feeds.

Symptoms

Because JEB‑PA affects both skin and the gastrointestinal tract, the symptom list is broader than for isolated JEB.

Skin‑related manifestations

  • Blistering and erosions: tense or flaccid blisters develop after minimal trauma (e.g., diaper changes, handling).
  • Granulation tissue and scarring: repeated injury leads to hypertrophic scars, especially on the hands, feet, and around joints.
  • Presence of milia: small keratin‑filled cysts appear on the face and trunk.
  • Onychodystrophy: nail dystrophy or loss is common.
  • Hair abnormalities: alopecia or sparse, brittle hair may be noted.
  • Oral mucosal lesions: blisters inside the mouth, on the tongue and palate, causing feeding difficulty.

Gastrointestinal manifestations (Pyloric Atresia)

  • Projectile vomiting: non‑bilious, often begins within the first 24‑48 hours after birth once feeds are introduced.
  • Failure to thrive: poor weight gain due to inability to ingest and absorb nutrients.
  • Dehydration and electrolyte imbalance: secondary to persistent vomiting.
  • Abdominal distention: may be modest because the obstruction is proximal.

Other systemic features

  • Respiratory involvement: rare, but some infants develop airway mucosal fragility.
  • Renal abnormalities: occasional reports of renal tubular dysfunction, likely secondary to genetic defect.

Causes and Risk Factors

JEB‑PA results from mutations that disrupt the proteins anchoring the epidermis to the basement membrane and, concurrently, affect the development of the pyloric muscle.

Genetic basis

  • ITGA6 (α6 integrin) and ITGB4 (ÎČ4 integrin) genes: Most cases involve biallelic loss‑of‑function mutations in these genes (CDC).
  • LAMA3, LAMB3, LAMC2: Rarely, mutations in laminin‑332 subunits produce a similar phenotype.

Inheritance pattern

Autosomal recessive – each parent is typically an asymptomatic carrier. The risk for each subsequent pregnancy is 25 %.

Risk factors

  • Consanguineous marriage (first‑cousin or closer).
  • Family history of epidermolysis bullosa or unexplained neonatal gastric obstruction.
  • Certain ethnic groups with higher carrier frequencies (e.g., some Middle‑Eastern and South‑Asian populations).

Diagnosis

Early recognition is crucial because the gastrointestinal obstruction can be life‑threatening, and skin care must be instituted promptly.

Clinical evaluation

  • Detailed birth and family history, focusing on consanguinity and prior affected siblings.
  • Physical examination noting blister distribution, presence of milia, and signs of pyloric obstruction (non‑bilious vomiting, upper abdominal fullness).

Laboratory and imaging studies

  • Abdominal ultrasound: reveals a distended stomach with an absent or narrowed pyloric canal.
  • Upper gastrointestinal (GI) contrast study: classic “single bubble” sign confirming pyloric atresia.
  • Skin biopsy with immunofluorescence mapping (IFM): shows absent or reduced expression of α6ÎČ4 integrin at the basement membrane.
  • Genetic testing: targeted gene panels or whole‑exome sequencing to identify pathogenic variants in ITGA6, ITGB4, or related genes.

Additional assessments

  • Baseline electrolyte panel and renal function tests (due to risk of dehydration and possible renal involvement).
  • Ophthalmology and dental evaluations, as mucosal fragility can affect eyes and teeth.

Treatment Options

There is no cure; management focuses on supportive care, preventing complications, and addressing the pyloric blockage.

1. Surgical correction of pyloric atresia

  • Pyloroplasty or gastro‑jejunostomy: Performed within the first weeks of life to restore gastric outflow. Success rates exceed 90 % when performed by experienced pediatric surgeons (Cleveland Clinic).
  • Post‑operative nutritional support (parenteral or enteral) until the infant tolerates feeds.

2. Skin care and wound management

  • Gentle handling: Use soft bedding, avoid adhesive tapes, and handle the infant with lint‑free gloves.
  • Barrier creams and emollients: Petrolatum‑based ointments protect intact skin; avoid petroleum‑jelly on open wounds.
  • Non‑adhesive dressings: Silicone, hydrocolloid, or MepilexÂź dressings reduce pain and trauma.
  • Infection control: Topical antimicrobials (e.g., mupirocin) for colonized wounds; systemic antibiotics only when infection is proven.
  • Pain management: Acetaminophen, ibuprofen (if renal function allows), or low‑dose opioid regimens under specialist guidance.

3. Nutritional support

  • High‑calorie, protein‑rich formulas once oral intake is possible.
  • If oral feeding is limited by oral mucosal blisters, consider nasogastric feeding or gastrostomy tube after surgical repair.

4. Pharmacologic therapies

  • Systemic retinoids (e.g., acitretin): May reduce blister formation in some JEB subtypes but have limited evidence in JEB‑PA and carry hepatotoxicity risks; use only in specialist centers.
  • Antifibrotic agents (e.g., tranexamic acid): Occasionally employed to limit scar formation, though data are anecdotal.

5. Multidisciplinary follow‑up

Optimal care involves a team: pediatric dermatologist, pediatric surgeon, gastroenterologist, nutritionist, genetic counselor, and psychosocial support services.

Living with Junctional Epidermolysis Bullosa with Pyloric Atresia

Families adapt to a lifelong condition that requires vigilance and routine care.

Daily skin care routine

  1. Gently cleanse with lukewarm water and a mild, fragrance‑free cleanser.
  2. Pat dry—do not rub.
  3. Apply a thin layer of barrier ointment within 5 minutes of drying.
  4. Cover new blisters with non‑adhesive dressings; change dressings daily or sooner if saturated.

Feeding & nutrition

  • Offer small, frequent feeds after surgical repair.
  • Monitor weight daily for the first 3 months; aim for a gain of 20–30 g/day.
  • Consider a dietitian‑supervised high‑energy formula if weight gain stalls.

Home environment modifications

  • Use soft, breathable clothing (cotton, bamboo); avoid wool, synthetic fibers, and tight elastic bands.
  • Keep nails trimmed to prevent accidental scratching.
  • Maintain a cool, humidity‑controlled room to reduce skin drying.

Psychosocial support

  • Connect with patient advocacy groups such as the Dystrophic Epidermolysis Bullosa Research Association (DEBRA).
  • Seek counseling for parents—chronic illness can lead to caregiver burnout.
  • School‑age children benefit from individualized education plans (IEPs) that address skin‑care needs and possible anxiety.

Prevention

Because JEB‑PA is genetic, primary prevention focuses on informed reproductive choices.

  • Carrier screening: Couples with known family history or from high‑risk populations should consider pre‑conception genetic testing for ITGA6/ITGB4 mutations.
  • Prenatal diagnosis: Chorionic villus sampling (CVS) or amniocentesis with targeted molecular analysis can detect pathogenic variants.
  • Pre‑implantation genetic diagnosis (PGD): For couples undergoing in‑vitro fertilization, embryos without the disease‑causing mutations can be selected.
  • Avoid skin trauma: While it does not prevent the genetic disease, minimizing friction injuries reduces blister burden and secondary infection.

Complications

If inadequately managed, JEB‑PA can lead to serious, sometimes life‑threatening sequelae.

  • Sepsis: Open skin wounds are portals for bacteria; bloodstream infection is a leading cause of mortality in severe EB.
  • Malnutrition and growth failure: Persistent vomiting, feeding difficulties, and increased metabolic demands.
  • Severe anemia: Chronic blood loss from skin erosions.
  • Hypertrophic scarring and contractures: May restrict joint motion and require physiotherapy or surgical release.
  • Renal insufficiency: Reported in a minority of patients, possibly linked to integrin dysfunction.
  • Psychological impact: Depression, anxiety, and social isolation are common without adequate support.

When to Seek Emergency Care

Call 911 or go to the nearest Emergency Department if your child shows any of the following:
  • Sudden, profuse vomiting that does not improve with positioning.
  • Signs of dehydration – dry mouth, sunken eyes, absence of tears, or a sudden drop in urine output.
  • Fever ≄ 38 °C (100.4 °F) accompanied by worsening skin blisters or foul‑smelling discharge.
  • Rapid heart rate (> 180 bpm in infants) or breathing difficulties.
  • Sudden increase in size of a blister that becomes extremely painful, tense, or turns purple/black (possible infection or compartment syndrome).
  • Any bleeding that cannot be stopped with gentle pressure.

© 2026 HealthGuide Corp. All information provided is for educational purposes and should not replace personalized medical advice. Consult your healthcare provider for diagnosis and treatment tailored to your situation.

⚠ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.